Kulkarni Samarth Insider Trades

Insider Trading History

Track insider trading activity for Kulkarni Samarth. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $74.4k 40,000 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68.4k 40,000 shares
$1.71
$1.86
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Director
Holding Value $0 0 shares
Last Trade
Jun 24, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$15.9M 392,474 shares
$40.50
$40.50
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $12.9M 255,501 shares
Last Trade
Mar 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$469k 10,020 shares
$46.78
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $5.77M 114,249 shares
Last Trade
Mar 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.07M 196,124 shares
$46.24
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $1.99M 39,375 shares
Last Trade
Mar 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$910k 19,687 shares
$46.24
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $13.4M 265,521 shares
Last Trade
Mar 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$910k 19,687 shares
$46.24
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $12.4M 245,834 shares
Last Trade
Mar 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$499k 10,349 shares
$48.26
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $3.12M 61,875 shares
Last Trade
Mar 14, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.01M 20,625 shares
$48.75
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $12.9M 256,183 shares
Last Trade
Mar 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.01M 20,625 shares
$48.75
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $11.9M 235,558 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$517k 9,798 shares
$52.80
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $971k 19,250 shares
Last Trade
Mar 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.02M 19,250 shares
$52.80
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $12.4M 245,356 shares
Last Trade
Mar 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.02M 19,250 shares
$52.80
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $11.4M 226,106 shares
Last Trade
Feb 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$366k 6,967 shares
$52.58
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $11.8M 233,073 shares
Last Trade
Feb 18, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$709k 13,250 shares
$53.52
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Feb 18, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$709k 13,250 shares
$53.52
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $6.77M 134,201 shares
Last Trade
Jan 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.61M 60,000 shares
$60.23
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $10.2M 202,768 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.55M 30,000 shares
$51.75
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $11.3M 224,201 shares
Last Trade
Dec 18, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.65M 30,000 shares
$54.84
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $12.8M 254,201 shares
Last Trade
Oct 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.46M 50,895 shares
$67.91
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Executive Officer
Holding Value $15.4M 305,096 shares
Last Trade
Oct 16, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.84M 100,000 shares
$68.43
$50.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up